• 1
    Beck AD. The effect of intra-uterine urinary obstruction upon the development of the fetal kidney. J Urol 1971; 105: 7849
  • 2
    Thomas DFM. Fetal urology and prenatal diagnosis. In BelmanAB, KingLR, KramerSA eds, Clinical Pediatric Urology, 4th edn. Chapt. 4. London: Martin Dunitz Ltd, 2002: 6582
  • 3
    Nguyen HT, Kogan BA. Upper urinary tract obstruction. experimental and clinical aspects. BJU Int 1998; 81: 13 21
  • 4
    Lakshmanan Y, Fung LCT. Anomalies of the renal collecting system. In BelmanAB, KingLR, KramerSA eds, Clinical Pediatric Urology, 4th edn. Chapt. 20. London: Martin Dunitz Ltd, 2002: 559631
  • 5
    Josephson S, Robertson B, Claesson G, Wikstad I. Experimental obstructive hydronephrosis in newborn rats. I. Surgical technique and long-term morphologic effects. Invest Urol 1980; 17: 47883
  • 6
    Cox PG, Moons MM, Slegers JF, Russel FG, Van Ginneken CA. Isolated perfused rat kidney as a tool in the investigation of renal handling and effects of nonsteroidal anti-inflammatory drugs. J Pharmacol Meth 1990; 24: 89103
  • 7
    Brink HM, Slegers JFG. Instantaneous measurement of glomerular filtration rate in the isolated perfused kidney. Eur J Physiol 1979; 383: 713
  • 8
    Masereeuw R, Moons MM, Russel FGM. Rhodamine 123 accumulates extensively in the isolated perfused rat kidney and is secreted by the organic cation system. Eur J Pharmacol 1997; 321: 31523
  • 9
    Masereeuw R, Moons MM, Toomey BH, Russel FGM, Miller DS. Active Lucifer Yellow secretion in renal proximal tubule: evidence for organic anion transport system crossover. J Pharmacol Exp Ther 1999; 289: 110411
  • 10
    Evers R, Kool M, Smith AJ, Van Deemter L, De Haas M, Borst P. Inhibitory effect of the reversal agents V-104, GF120918 and Pluronic L61 on MDR1 Pgp. Br J Cancer 2000; 83: 36674
  • 11
    Mircheff AK, Wright EM. Analytical isolation of plasma membranes of intestinal epithelial cells: identification of Na, K-ATPase rich membranes and the distribution of enzyme activities. J Membr Biol 1976; 28: 30933
  • 12
    Müller-Suur R. Radiopharmaceuticals. their intrarenal handling and localization. In MurrayIPC, EllPJ eds, Nuclear Medicine in Clinical Diagnosis and Treatment. 2nd edn. Vol. 1. Section 2, Chapt. 21. London: Churchill Livingstone, 1998: 21128
  • 13
    Van Acker BA, Koomen GC, Koopman MG, De Waart DR, Arisz L. Creatinine clearance during cimetidine administration for measurement of glomerular filtration rate. Lancet 1992; 340: 13269
  • 14
    Gordon I. Nuclear medicine in uronephrology. In O'DonellB, KoffSA eds, Pediatric Urology, 3rd Edn. Part 2, Chapt. 7. Oxford: Butterworth–Heinemann, 1997: 7489
  • 15
    Müller-Suur R, Gutsche HU. Tubular reabsorption of Tc-DMSA. J Nucl Med 1995; 36: 16548
  • 16
    Rehling M, Nielsen LE, Marqversen J. Protein binding of [99mTc]DTPA, [51Cr]EDTA and [125I]Iothalamate. Nucl Med Comm 1997; 18: 324
  • 17
    Müller-Suur R, Gutsche HU. No evidence for tubular reabsorption of DMSA and MMAG-3. Eur J Nucl Med 1994; 21: S124
  • 18
    Yee CA, Lee HB, Blaufox MD. Tc-99m DMSA renal uptake. influence of biochemical and physiologic factors. J Nucl Med 1982; 22: 10548
  • 19
    Moretti JL, Rapin JR, Saccavini JC, Lageron A, Le Poncin M, Bardy A. Dimercaptosuccinic-acid chelates. 2 Renal localization. Int J Nucl Med Biol 1981; 11: 2759
  • 20
    Goldraich NP, Alvarenga AR, Goldraich IH. Renal accumulation of Tc-99m DMSA in the artificially perfused rat-kidney. J Urol 1985; 134: 12826
  • 21
    Gier RPE, Feitz WFJ, Masereeuw R, Wouterse AC, Smits D, Russel FGM. Anionic and cationic drug secretion in the isolated perfused rat kidney after neonatal surgical induction of ureteric obstruction. BJU Int 2002; 89 (Suppl. 2): 45, A75